Clinical Trials on CDI

Total 166 results

Intermountain Health Care, Inc.

Completed

Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention (PASTCDI)

CDI

United States
Finch Research and Development LLC.
Medpace, Inc.

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT)

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal Transplant

United States, Canada
Creighton University

Withdrawn

Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDI

CDI

United States
NYU Langone Health

Completed

Fenfluramine in CDKL5 Deficiency Disorder (CDD)

CDD

United States
University of Minnesota
Wyeth is now a wholly owned subsidiary of Pfizer; Roche Pharma AG; Genzyme, a...

Completed

Calcineurin Inhibitor Sparing After Kidney Transplantation (CNI-Sparing)

CNI Side Effects

United States
Sheng-Teng Huang

Completed

To Investigate the Metabolomics in the Subjects With Long Term Tai Chi Chuan Practice

Metabolomics | Tai Chi Chuan

Taiwan
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet

Healthy Subjects | Drug-Drug Interaction (DDI)

France
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts

CD4 Lymphocytopenia | Idiopathic CD4 Positive T Lymphocytopenia

United States
Theravance Biopharma

Completed

Drug-Drug Interaction (DDI) Study for TD-9855

Drug Drug Interaction (DDI)

United States
AstraZeneca
Parexel

Completed

A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy Volunteers

Healthy Volunteer/DDI Study

United Kingdom
University of Siena

Unknown

Clinical Study of Porcelain-fused and IPS e.Max CAD Crowns

Survival | Success | CDA Index

Italy
The Hong Kong Polytechnic University

Completed

The Relationship Between Cranial Near-InfraRed Oxygenation(NIRO) and Heart Rate Variability During Mental Exercise

Tai Chi Practitioner | Qigong Practitioner

China
National Institute of Allergy and Infectious Diseases...

Terminated

Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

Idiopathic CD4+ T-Lymphocytopenia

United States
Bayer

Completed

Interaction With HIV Antiretroviral Agents

HIV-DDI

United States
ImmuniMed Inc.
University of Manitoba; University of Calgary

Recruiting

Treatment of Mild-moderate Clostridium Difficile Infection (CDI) (IM-01)

Clostridium Difficile Infection (CDI)

Canada
ProgenaBiome

Recruiting

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection

Clostridium Difficile Infection | Microbiome | Clostridium Difficile | CDI

United States
University of Michigan
Merck Sharp & Dohme LLC

Completed

A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections

Clostridium Difficile Infection (CDI)

United States
Astellas Pharma Europe B.V.

Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

Healthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)

Germany
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects

Healthy Subjects | Drug-Drug Interaction (DDI)

United Kingdom
University of Colorado, Denver
National Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaborators

Recruiting

International CDKL5 Clinical Research Network (ICCRN)

CDKL5 | CDKL5 Deficiency Disorder | CDD

United States, Australia
Astellas Pharma Europe B.V.
Medivation, Inc.

Completed

A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men

Healthy Subjects | Drug-Drug Interaction (DDI) | Pharmacokinetics of Enzalutamide

Germany
University of Wisconsin, Madison
Agency for Healthcare Research and Quality (AHRQ)

Completed

The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation (GRAFT)

Clostridium Difficile Infection | CDI | C.Difficile Diarrhea

United States
Astellas Pharma Europe B.V.

Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

Healthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)

Germany
Anhui Medical University

Completed

Exercise Interventions on Problematic Mobile Phone Use: a Multi-arm Randomized Controlled Trial

Randomized Clinical Trial | Intestinal Flora | Exercise Intervention | Tai Chi Chuan

China
Loyola University Chicago

Completed

Black Men Evolving Behavioral HIV Prevention Intervention for Black MSM (B-ME)

HIV CDC Category A1

United States
Cornelius Clancy
Merck Sharp & Dohme LLC

Enrolling by invitation

Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)

Clostridium Difficile Infection (CDI)

United States
Rebiotix Inc.

Completed

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

Clostridium Difficile Infection (CDI)

United States, Canada
China Medical University Hospital

Completed

Functional Plasticity of Human IL-17-producing CD8+ T Cells

IL-17+ CD8 T Cells in Cancer Patients

Taiwan
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy

CD7+ Acute Leukemia | CD7+ Lymphoma

China
University of Illinois at Chicago
National Institute of Nursing Research (NINR); Kamuzu College of Nursing, University...

Completed

A Community-based Implementation Model for HIV Prevention and Testing in Malawi

HIV CDC Category A1

Malawi
Statens Serum Institut
European and Developing Countries Clinical Trials Partnership (EDCTP); Ministry...

Completed

HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease (HIV-BIS)

Aids, Cdc Group I

Guinea-Bissau
Gilead Sciences
Nimbus Apollo

Completed

Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects

PD Effects of GS-0976 (NDI-010976) on Fractional DNL

United States
Pluristem Ltd.

Unknown

Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Critical Limb Ischemia (CLI)

Germany, United Kingdom, Hungary, United States, Bulgaria, Czechia, Israel, North Macedonia, Poland
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects

Healthy Subjects | Pharmacokinetics | DDI (Drug-Drug Interaction)

Germany
University of Pennsylvania
International Foundation for CDKL5 Research; Loulou Foundation; CDKL5 Alliance

Recruiting

International CDKL5 Registry

CDKL5 Deficiency Disorder (CDD)

United States
Astellas Pharma Europe B.V.
Cubist Pharmaceuticals LLC

Completed

A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects

Healthy Subjects | Drug-Drug Interaction (DDI) | Intestinal Absorption | Pharmacokinetics of Rosuvastatin | Pharmacokinetics of Fidaxomicin

Germany
Glycomine, Inc.

Recruiting

24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG

Pmm2-CDG

Spain, Australia, United States
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease (GENIUS)

Critical Limb Ischemia (CLI)

China
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Terminated

Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin

Critical Limb Ischemia (CLI)

Spain
Ministry of Health and Child Welfare, Zimbabwe

Completed

Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses

Circumcision Adult | HIV CDC Category B2

Zimbabwe
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Limb Ischemia (CLI).

Critical Limb Ischemia (CLI)

Spain
National Institute of Allergy and Infectious Diseases...

Recruiting

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Idiopathic CD4-Positive | T-Lymphocytopenia

United States
Instituto Nacional de Ciencias Medicas y Nutricion...

Suspended

Pyridostigmine as Immunomodulator in People Living With HIV

HIV-1-infection | Immune Deficiency | CD4+ T Lymphocytopenia | Immuno-senescence

Mexico
Pluristem Ltd.

Available

Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Critical Limb Ischemia (CLI)

United States
WideTrial, Inc.

Available

Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI)

Critical Limb Ischemia (CLI)
Cesca Therapeutics, Inc.

Unknown

Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System (CLIRST III)

Critical Limb Ischemia (CLI)
Orpha Labs

Unknown

Study of ORL-1M (D-mannose) in Patients With CDG-Ib

CDG Ib

Turkey
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie; Gilead Sciences; Roche Pharma AG; Takeda; Celgene; Biogen

Active, not recruiting

Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up (CREDO2)

CD

Belgium, France
Eva Morava-Kozicz

Not yet recruiting

AVTX-801 D-galactose Supplementation in SLC35A2-CDG

SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation

United States
Balton Sp.zo.o.
KCRI

Completed

Clinical Study to Assess the Safety and Efficacy of Mechanochemical Ablation With Flebogrif in Patients With Great Saphenous Vein Insufficiency (POLFLEB)

Chronic Venous Insufficiency, CVI

Poland

Clinical Trials on CDI

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations